Home > Insider Trading > Filing (0001209191-18-018856)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
917520	Integra Lifesciences Holdings Corp	IART	Laboratory Analytical Instruments (3826)	510317849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187576	E Richard Caruso	795 E Lancaster Avenue, Suite 200 Villanova PA 19085		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-03-08	12,002	$18.06	146,136	No	4	M	Direct
Common Stock	Disposition	2018-03-08	12,002	$53.68	134,134	No	4	S	Direct
Common Stock	Acquisiton	2018-03-08	20,878	$18.06	155,012	No	4	M	Direct
Common Stock	Disposition	2018-03-08	20,878	$53.68	134,134	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-03-08	12,002	$0.00	12,002	$18.06
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-03-08	20,878	$0.00	20,878	$18.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2018-05-19	No	4	M	Direct
0		2018-05-19	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	46,676	Indirect	By Corporation
Common Stock	11,982,410	Indirect	By Partnership
Common Stock	4,000	Indirect	By Son

Footnotes

On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $53.37 to $54.
25% of the stock options vest every quarter from the grant date of 5/19/2010
This option was previously reported as covering 5,749 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 6,001 shares of common stock at an exercise price of $36.12 per share.
In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
This option was previously reported as covering 10,000 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 10,439 shares of common stock at an exercise price of $36.12 per share.